-
C Allemani, T Matsuda, V Di Carlo, R Harewood, M Matz, M Niksic, A Bonaventure, M Valkov, CJ Johnson, J Esteve, OJ Ogunbiyi, ESG Azevedo, WQ Chen, S Eser, G Engholm, CA Stiller, A Monnereau, RR Woods, O Visser, GH Lim, J Aitken, HK Weir, MP Coleman, and CW Group, Global surveillance of trends in cancer survival 2000 14 (CONCORD 3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population based registries in 71 countries. Lancet, 2018 .39 110125 ): p. 1023 1075
-
JJ Sung, SC Ng, FK Chan, HM Chiu, HS Kim, T Matsuda, SS Ng, JY Lau, S Zheng, S Adler, N Reddy, KG Yeoh, KK Tsoi, JY Ching, EJ Kuipers, L Rabeneck, GP Young, RJ Steele, D Lieberman, KL Goh, and G Asia Pacific Working, An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut, 2015. 64(1): p. 121-32.
-
Statistics adapted from the American Cancer Society's (ACS) publication, Cancer Facts & Figures 2020 and the ACS website (January 2020).
-
SH Wong and J Yu, Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat Rev Gastroenterol Hepatol, 2019. 16(11): p. 690-704.
-
SH Wong, L Zhao, X Zhang, G Nakatsu, J Han, W Xu, X Xiao, TNY Kwong, H Tsoi, WKK Wu, B Zeng, FKL Chan, JJY Sung, H Wei, and J Yu, Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice. Gastroenterology, 2017. 153(6): p. 1621-1633 e6.
-
G Nakatsu, X Li, H Zhou, J Sheng, SH Wong, WK Wu, SC Ng, H Tsoi, Y Dong, N Zhang, Y He, Q Kang, L Cao, K Wang, J Zhang, Q Liang, J Yu, and JJ Sung, Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat Commun, 2015. 6: p.8727.
-
Z Dai, OO Coker, G Nakatsu, WKK Wu, L Zhao, Z Chen, FKL Chan, K Kristiansen, JJY Sung, SH Wong, and J Yu, Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers. Microbiome, 2018. 6(1): p. 70.
-
J Yu, Q Feng, SH Wong, D Zhang, QY Liang, Y Qin, L Tang, H Zhao, J Stenvang, Y Li, X Wang, X Xu, N Chen, WK Wu, J Al-Aama, HJ Nielsen, P Kiilerich, BA Jensen, TO Yau, Z Lan, H Jia, J Li, L Xiao, TY Lam, SC Ng, AS Cheng, VW Wong, FK Chan, X Xu, H Yang, L Madsen, C Datz, H Tilg, J Wang, N Brunner, K Kristiansen, M Arumugam, JJ Sung, andJ Wang, Metagenomic analysis of faecal microbiome as a tool towards targeted noninvasive biomarkers for colorectal cancer. Gut, 2017. 66(1): p. 70-78.
-
Q Liang, J Chiu, Y Chen, Y Huang, A Higashimori, J Fang, H Brim, H Ashktorab, SC Ng, SSM Ng, S Zheng, FKL Chan, JJY Sung, and J Yu, Fecal Bacteria Act as Novel Biomarkers for Noninvasive Diagnosis of Colorectal Cancer. Clin Cancer Res, 2017. 23(8):p. 2061-2070.
-
JQ Liang, T Li, G Nakatsu, YX Chen, TO Yau, E Chu, S Wong, CH Szeto, SC Ng, FKL Chan, JY Fang, JJY Sung, and J Yu, A novel faecal Lachnoclostridium marker for the noninvasive diagnosis of colorectal adenoma and cancer. Gut, 2019.
-
TF Imperiale, DF Ransohoff, SH Itzkowitz, TR Levin, P Lavin, GP Lidgard, DA Ahlquist, and BM Berger. Multitarget Stool DNA Testing for Colorectal-Cancer Screening. The New England Journal of Medicine, 2014.
- US patent Assessing Risk for Colorectal Adenoma Recurrence by Noninvasive Means (1st Provisional Application No. 63/116104, Filing date: 19 Nov 2020); US patent Assessing Risk for Colorectal Adenoma Recurrence by Noninvasive Means (2nd Provisional Application No. 63/196582, Filing date: 3 Jun 2021)
M3CRC™ (“Test”) is not a diagnostic test. The test result of the Test should be interpreted with caution. A test result of "low" to "medium" risk of having colorectal adenoma and "low" risk of having colorectal cancer does not guarantee the absence of colorectal adenoma and/or colorectal cancer. A test result of "medium-high" or higher risk of having colorectal adenoma and "medium" or higher risk of having colorectal cancer does not guarantee the presence of colorectal adenoma and/or colorectal cancer. A test result of “low” risk of recurrence does not guarantee the absence of recurrence. A test result of “high” risk of recurrence does not guarantee the presence of recurrence. The screening interval for the Test has not been established. This leaflet is not intended to serve as a substitute for professional medical help or advice. If you have any questions regarding the above information, always seek advice from your doctor.